Neumann Clarke's most recent trade in Biora Therapeutics Inc was a trade of 26,629 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on Aug. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 15 Aug 2024 | 26,629 | 465,564 | - | 0.7 | 17,841 | Common Stock |
| Biora Therapeutics Inc | Neumann Clarke | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 230,000 | 492,193 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 210,175 | 262,193 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.14 per share. | 15 Aug 2023 | 36,183 | 52,018 | - | 3.1 | 113,615 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 15 May 2023 | 2,368 | 88,201 | - | 3.4 | 7,933 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 57,950 | 79,568 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 21,684 | 101,252 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 15 Mar 2023 | 10,683 | 90,569 | - | 2.6 | 27,348 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.46 per share. | 15 Feb 2023 | 84 | 21,618 | - | 3.5 | 291 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jan 2023 | 44 | 0 | - | - | Series X Preferred Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.27 per share. | 15 Nov 2022 | 4,529 | 542,398 | - | 0.3 | 1,223 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.04 per share. | 15 Aug 2022 | 1,355 | 546,927 | - | 1.0 | 1,409 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2022 | 387,752 | 387,752 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2022 | 239,962 | 548,282 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 15 May 2022 | 8,305 | 308,320 | - | 0.8 | 6,229 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2022 | 299,197 | 299,197 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2022 | 184,843 | 316,625 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.90 per share. | 15 Feb 2022 | 1,716 | 131,782 | - | 1.9 | 3,260 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 15 Nov 2021 | 752 | 133,498 | - | 3.5 | 2,609 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 15 Aug 2021 | 2,336 | 134,250 | - | 1.7 | 3,878 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 15 May 2021 | 1,505 | 136,586 | - | 2.4 | 3,552 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 183,265 | 183,265 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 87,356 | 138,091 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Clarke Neumann | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 89,137 | 89,137 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Clarke Neumann | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 04 Mar 2021 | 1,564 | 50,735 | - | 4.0 | 6,334 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. | 15 Feb 2021 | 663 | 52,299 | - | 5.6 | 3,713 | Common Stock |
| Biora Therapeutics Inc | Clarke Neumann | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.32 per share. | 19 Dec 2020 | 1,726 | 52,962 | - | 6.3 | 10,908 | Common Stock |